A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19
Immunity Inflammation and Disease (2022) - Comments
pubmed: 34762351  doi: 10.1002/iid3.563  issn: 2050-4527 

Amir Behnam Kharazmi, Omid Moradi, Mehrdad Haghighi, Mehran Kouchek, Alireza Manafi‐Rasi, Masoomeh Raoufi, ‪Simin Dokht Shoaei, Fahimeh Hadavand, Mahmood Nabavi, Mir Mohammad Miri, Sara Salarian, Seyedpouzhia Shojaei, Shayesteh Khalili, Mohammad Sistanizad, Setayesh Sadeghi, Amirhossein Karagah, Saemeh Asgari, Morteza Jaffaraghaei, Shahram Araghi